MicroRNAs and the functional β cell mass: For better or worse

Diabetes and Metabolism

Volumn 41, Issue 5, 2015, Pages 369-377

  Guay, C ^a   Regazzi, R ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Diabetes; Gene regulation; MicroRNAs; Pancreatic islets; cells

Indexed keywords

DICER; DICER 1; GLUCOSE; INSULIN; MICRORNA; MICRORNA 375; SMALL UNTRANSLATED RNA; TAMOXIFEN; UNCLASSIFIED DRUG;

BLOOD SAMPLING; CELL DEATH; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; DIABETIC PATIENT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PREGNANCY DIABETES MELLITUS; RECEPTOR DOWN REGULATION; REGULATOR GENE; REVIEW; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CYTOLOGY; GENE EXPRESSION REGULATION; IMPAIRED GLUCOSE TOLERANCE; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICRORNAS; MODELS, BIOLOGICAL; PREDIABETIC STATE;

EID: 84947036450     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2015.03.006     Document Type: Review

References (59)

1. Prentki M., Nolan C.J. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006, 116:1802-1812.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
3. miRBase. The microRNA database (online),. 2014. http://www.mirbase.org/.
4. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
5. Flynt A.S., Lai E.C. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 2008, 9:831-842.
6. Dumortier O., Hinault C., Van Obberghen E. MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab 2013, 18:312-324.
7. Esguerra J.L., Mollet I.G., Salunkhe V.A., Wendt A., Eliasson L. Regulation of pancreatic beta cell stimulus-secretion coupling by microRNAs. Genes (Basel) 2014, 5:1018-1031.
8. Ozcan S. Minireview: microRNA function in pancreatic beta cells. Mol Endocrinol 2014, [me20141306].
9. Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R. Diabetes mellitus, a microRNA-related disease?. Transl Res 2011, 157:253-264.
10. Shantikumar S., Caporali A., Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 2012, 93:583-593.
11. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., et al. Dicer is essential for mouse development. Nat Genet 2003, 35:215-217.
12. Morita S., Hara A., Kojima I., Horii T., Kimura M., Kitamura T., et al. Dicer is required for maintaining adult pancreas. PLoS One 2009, 4:e4212.
13. Lynn F.C., Skewes-Cox P., Kosaka Y., McManus M.T., Harfe B.D., German M.S. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 2007, 56:2938-2945.
14. Kanji M.S., Martin M.G., Bhushan A. Dicer1 is required to repress neuronal fate during endocrine cell maturation. Diabetes 2013, 62:1602-1611.
15. Kalis M., Bolmeson C., Esguerra J.L., Gupta S., Edlund A., Tormo-Badia N., et al. Beta cell-specific deletion of dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One 2011, 6:e29166.
16. Mandelbaum A.D., Melkman-Zehavi T., Oren R., Kredo-Russo S., Nir T., Dor Y., et al. Dysregulation of Dicer1 in beta cells impairs islet architecture and glucose metabolism. Exp Diabetes Res 2012, 2012:470302.
17. Melkman-Zehavi T., Oren R., Kredo-Russo S., Shapira T., Mandelbaum A.D., Rivkin N., et al. miRNAs control insulin content in pancreatic beta cells via downregulation of transcriptional repressors. Embo J 2011, 30:835-845.
18. Tattikota S.G., Rathjen T., McAnulty S.J., Wessels H.H., Akerman I., van de Bunt M., et al. Argonaute2 mediates compensatory expansion of the pancreatic beta cell. Cell Metab 2014, 19:122-134.
19. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
20. Su J.L., Chen P.S., Johansson G., Kuo M.L. Function and regulation of let-7 family microRNAs. Microrna 2012, 1:34-39.
21. Kameswaran V., Bramswig N.C., McKenna L.B., Penn M., Schug J., Hand N.J., et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab 2014, 19:135-145.
22. van de Bunt M., Gaulton K.J., Parts L., Moran I., Johnson P.R., Lindgren C.M., et al. The miRNA profile of human pancreatic islets and beta cells and relationship to type 2 diabetes pathogenesis. PLoS One 2013, 8:e55272.
23. Frost R.J., Olson E.N. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc Natl Acad Sci U S A 2011, 108:21075-21080.
24. Zhu H., Shyh-Chang N., Segre A.V., Shinoda G., Shah S.P., Einhorn W.S., et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011, 147:81-94.
25. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
26. El Ouaamari A., Baroukh N., Martens G.A., Lebrun P., Pipeleers D., van Obberghen E. miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta cells. Diabetes 2008, 57:2708-2717.
27. Keller D.M., McWeeney S., Arsenlis A., Drouin J., Wright C.V., Wang H., et al. Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem 2007, 282:32084-32092.
28. Kloosterman W.P., Lagendijk A.K., Ketting R.F., Moulton J.D., Plasterk R.H. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 2007, 5:e203.
29. Poy M.N., Hausser J., Trajkovski M., Braun M., Collins S., Rorsman P., et al. miR-375 maintains normal pancreatic alpha and beta cell mass. Proc Natl Acad Sci U S A 2009, 106:5813-5818.
30. Esguerra J.L., Bolmeson C., Cilio C.M., Eliasson L. Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS One 2011, 6:e18613.
31. Nesca V., Guay C., Jacovetti C., Menoud V., Peyot M.L., Laybutt D.R., et al. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 2013, 56:2203-2212.
32. Zhao E., Keller M.P., Rabaglia M.E., Oler A.T., Stapleton D.S., Schueler K.L., et al. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome 2009, 20:476-485.
33. Sebastiani G., Po A., Miele E., Ventriglia G., Ceccarelli E., Bugliani M., et al. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion. Acta Diabetol 2014.
34. Dumortier O., Hinault C., Gautier N., Patouraux S., Casamento V., Van Obberghen E. Maternal protein restriction leads to pancreatic failure in offspring: role of misexpressed microRNA-375. Diabetes 2014, 63:3416-3427.
35. Bravo-Egana V., Rosero S., Molano R.D., Pileggi A., Ricordi C., Dominguez-Bendala J., et al. Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun 2008, 366:922-926.
36. Correa-Medina M., Bravo-Egana V., Rosero S., Ricordi C., Edlund H., Diez J., et al. MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr Patterns 2009, 9:193-199.
37. Kredo-Russo S., Ness A., Mandelbaum A.D., Walker M.D., Hornstein E. Regulation of pancreatic microRNA-7 expression. Exp Diabetes Res 2012, 2012:695214.
38. Nieto M., Hevia P., Garcia E., Klein D., Alvarez-Cubela S., Bravo-Egana V., et al. Antisense miR-7 impairs insulin expression in developing pancreas and in cultured pancreatic buds. Cell Transplant 2012, 21:1761-1774.
39. Latreille M., Hausser J., Stutzer I., Zhang Q., Hastoy B., Gargani S., et al. MicroRNA-7a regulates pancreatic beta cell function. J Clin Invest 2014, 124:2722-2735.
40. Wang Y., Liu J., Liu C., Naji A., Stoffers D.A. MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic beta cells. Diabetes 2013, 62:887-895.
41. Salzman J., Gawad C., Wang P.L., Lacayo N., Brown P.O. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One 2012, 7:e30733.
42. Hansen T.B., Kjems J., Damgaard C.K. Circular RNA and miR-7 in cancer. Cancer Res 2013, 73:5609-5612.
43. Memczak S., Jens M., Elefsinioti A., Torti F., Krueger J., Rybak A., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013, 495:333-338.
44. Ostenson C.G., Khan A., Abdel-Halim S.M., Guenifi A., Suzuki K., Goto Y., et al. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia 1993, 36:3-8.
45. Kornfeld J.W., Baitzel C., Konner A.C., Nicholls H.T., Vogt M.C., Herrmanns K., et al. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 2013, 494:111-115.
46. Lovis P., Roggli E., Laybutt D.R., Gattesco S., Yang J.Y., Widmann C., et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta cell dysfunction. Diabetes 2008, 57:2728-2736.
47. Filios S.R., Xu G., Chen J., Hong K., Jing G., Shalev A. MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis. J Biol Chem 2014, 289:36275-36283.
48. Xu G., Chen J., Jing G., Shalev A. Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nat Med 2013, 19:1141-1146.
49. Soni M.S., Rabaglia M.E., Bhatnagar S., Shang J., Ilkayeva O., Mynatt R., et al. Downregulation of Carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion. Diabetes 2014, 63:3805-3814.
50. Jacovetti C., Abderrahmani A., Parnaud G., Jonas J.C., Peyot M.L., Cornu M., et al. MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity. J Clin Invest 2012, 122:3541-3551.
51. Bolmeson C., Esguerra J.L., Salehi A., Speidel D., Eliasson L., Cilio C.M. Differences in islet-enriched miRNAs in healthy and glucose-intolerant human subjects. Biochem Biophys Res Commun 2011, 404:16-22.
52. Zhao H., Guan J., Lee H.M., Sui Y., He L., Siu J.J., et al. Upregulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta cell deficit and islet amyloid deposition. Pancreas 2010, 39:843-846.
53. Locke J.M., da Silva Xavier G., Dawe H.R., Rutter G.A., Harries L.W. Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia 2014, 57:122-128.
54. Baroukh N., Ravier M.A., Loder M.K., Hill E.V., Bounacer A., Scharfmann R., et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta cell lines. J Biol Chem 2007, 282:19575-19588.
55. Lovis P., Gattesco S., Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 2008, 389:305-312.
56. Guay C., Regazzi R. Role of islet microRNAs in diabetes: which model for which question?. Diabetologia 2015, 58:456-463.
57. Henquin J.C., Rahier J. Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia 2011, 54:1720-1725.
58. Meier J.J., Breuer T.G., Bonadonna R.C., Tannapfel A., Uhl W., Schmidt W.E., et al. Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia 2012, 55:1346-1354.
59. Wang D., Gu J., Wang T., Ding Z. OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs. Bioinformatics 2014, 30:2237-2238.